MEPSGEN
LIVE

Serial Number

79348988

Owner

MEPSGEN Co., LTD.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Apr 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MEPSGEN Trademark

Serial Number: 79348988 • Registration: 7490516

MEPSGEN is a trademark filed by MEPSGEN Co., LTD. on April 28, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

MEPSGEN Co., LTD. (3 trademarks)

7F, 12, Beobwon-ro 11-gil,

Entity Type: 03

Trademark Details

Filing Date

April 28, 2022

Registration Date

September 3, 2024

Published for Opposition

June 18, 2024

Goods & Services

Biochips for research or scientific purposes; biochip analyzing apparatus, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for inspecting biochips for laboratory use, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for analyzing biochips for laboratory use, namely, electronic biochip analysis device for analyzing functionality of biochips; apparatus for manufacturing biochips for laboratory use, namely, electronic installations for the remote control of industrial biochip manufacturing operations; laboratory apparatus for analyzing biological pharmaceuticals, namely, laboratory analysis device for analyzing efficacy, potency, and toxicity evaluations of biological pharmaceuticals; microchips

Crude medicines research; drug discovery services; development of cell therapy products; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; pharmaceutical drug development; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical studies in the nature of medical and scientific research, namely, conducting clinical trials for others, and translational research and medical and scientific research; scientific research services for medical purposes in the field of cancerous diseases, CNS diseases, and brain diseases; drug delivery, medicinal effect, Biological or biotechnological research for medical products; development of biotechnology, namely, medical drug and biochip products; biotechnology research; laboratory research in the field of biology; development of biologics, namely, vaccine and therapeutic drug products; research in the field of chemistry; technological studies in the nature of biotechnology and microfluidics research; research and development of medical equipment; development of medical devices; conducting clinical trials in the field of cardiovascular disease; conducting early efficacy, potency, and toxicity evaluations in the field of new pharmaceuticals; conducting early pharmaceutical product evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection, research of medical products; consultancy in the field of testing, inspection, and research of medical products, namely, pharmaceuticals, pharmaceutical preparations and pharmaceutical compositions; pharmaceutical product evaluation; design of devices for biological medicine analysis; development of devices for biological chemicals analysis; development of devices for biochemical chemicals; microchip design services

Wholesale store services featuring cell growth media for growing cells for use in scientific research; retail store services featuring cell growth media for growing cells for use in scientific research; wholesale store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; retail store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; wholesale store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring cardiovascular pharmaceuticals; retail store services featuring cardiovascular pharmaceuticals; wholesale store services featuring chemico-pharmaceutical preparations; retail store services featuring chemico-pharmaceutical preparations; wholesale store services featuring medical instruments; retail store services featuring medical instruments; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring biological preparations for medical or veterinary purposes; retail store services featuring biological preparations for medical or veterinary purposes; wholesale store services featuring biotechnological preparations for medical purposes; retail store services featuring biotechnological preparations for medical purposes; wholesale store services featuring biological reagents for medical purposes; retail store services featuring biological reagents for medical purposes; wholesale store services featuring biological tissue cultures for medical purposes; retail store services featuring biological tissue cultures for medical purposes; wholesale store services featuring biological preparations for medical purposes; retail store services featuring biological preparations for medical purposes; wholesale store services featuring living cells for medical purposes; retail store services featuring living cells for medical purposes; wholesale store services featuring cells for medical purposes; retail store services featuring cells for medical purposes; wholesale store services featuring cell culture instruments for medical use; retail store services featuring cell culture instruments for medical use; wholesale store services featuring cardiovascular agents for medical purposes; retail store services featuring cardiovascular agents for medical purposes; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring stem cells for medical purposes; retail store services featuring stem cells for medical purposes; wholesale store services featuring chemical preparations for medical purposes; retail store services featuring chemical preparations for medical purposes

Pharmaceutical products for treating respiratory diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; stimulants for the central nervous system; pharmaceutical preparations for tumor treatment; tissue- regenerative pharmaceutical preparations; pharmaceutical preparations for use in tissue transplantation; clinical diagnostic reagents; clinical medical reagents; pharmaceuticals for the treatment of Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, Cancer, Brain disease; pharmaceutical compositions for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; pharmaceutical drugs for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; cells for medical purposes; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the prevention of inflammatory disorders; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for immunity adjustment; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the prevention of diseases of the endocrine system; pharmaceutical products for the treatment of infectious diseases

Medical diagnostic apparatus for the detection of cardiovascular diseases; medical apparatus and instruments for use in medical examination and treatment of cardiovascular diseases; cell culture instruments for medical use, namely, cell culture chambers

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Aug 29, 2025 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 8, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 16, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 16, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 3, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 11, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 11, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
EXPARTE APPEAL TERMINATED
May 16, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 16, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 16, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 16, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 16, 2024 CNEA
EX PARTE APPEAL-INSTITUTED
May 14, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 14, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 14, 2024 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 29, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 3, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 14, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 14, 2023 GNFN
FINAL REFUSAL E-MAILED
Nov 14, 2023 GNFR
FINAL REFUSAL WRITTEN
Nov 14, 2023 CNFR
DATA MODIFICATION COMPLETED
Nov 1, 2023 DMCC
ASSIGNED TO LIE
Nov 1, 2023 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2023 TROA
REFUSAL PROCESSED BY IB
May 10, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 25, 2023 RFCR
NON-FINAL ACTION WRITTEN
Feb 24, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 13, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 8, 2022 REPR